NCT07497295

Brief Summary

Spinal anesthesia is commonly used in transurethral prostate resection (TUR-P) surgeries; however, post-spinal hypotension remains a frequent and clinically significant complication, particularly in elderly patients. Early prediction of hypotension may allow timely interventions and improve patient safety. This prospective observational study aims to evaluate the predictive value of preoperative ultrasound-based inferior vena cava collapsibility index (IVC-CI) and femoral vein collapsibility index (FVCI) for post-spinal hypotension in patients undergoing elective TUR-P under spinal anesthesia. Before spinal anesthesia, IVC and femoral vein measurements will be obtained using ultrasonography. Hemodynamic parameters will be recorded before and after spinal anesthesia, and the occurrence of hypotension will be assessed according to predefined criteria. The study seeks to compare the diagnostic performance of IVC-CI and FVCI in predicting post-spinal hypotension and to identify potential clinical predictors associated with hypotension in this patient population.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
110

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Jan 2026

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2026

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

March 23, 2026

Completed
4 days until next milestone

First Posted

Study publicly available on registry

March 27, 2026

Completed
19 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 15, 2026

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

May 30, 2026

Completed
Last Updated

March 27, 2026

Status Verified

March 1, 2026

Enrollment Period

3 months

First QC Date

March 23, 2026

Last Update Submit

March 23, 2026

Conditions

Keywords

Spinal AnesthesiaPost-Spinal HypotensionUltrasonographyInferior Vena Cava Collapsibility IndexFemoral Vein Collapsibility Index

Outcome Measures

Primary Outcomes (1)

  • Prediction of Post-Spinal Hypotension Using Inferior Vena Cava and Femoral Vein Collapsibility Indices

    The primary outcome is the predictive value of the inferior vena cava collapsibility index (IVC-CI) and femoral vein collapsibility index (FVCI) for the development of post-spinal hypotension. Hypotension is defined as a systolic blood pressure \<90 mmHg, a decrease in systolic blood pressure \>30% from baseline, or a mean arterial pressure \<60 mmHg within 15 minutes after spinal anesthesia.

    Within the first 15 minutes after spinal anesthesia

Secondary Outcomes (1)

  • Comparison of Diagnostic Performance of IVC-CI and FVCI for Post-Spinal Hypotension

    Within the first 15 minutes after spinal anesthesia

Study Arms (2)

Post-Spinal Hypotension Group

Patients who develop hypotension after spinal anesthesia according to predefined hemodynamic criteria.

Non-Hypotension Group

Patients who do not develop hypotension following spinal anesthesia.

Eligibility Criteria

Age18 Years - 75 Years
Sexmale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

The study population consists of adult male patients aged 18-75 years with American Society of Anesthesiologists (ASA) physical status I-III who are scheduled to undergo elective transurethral resection of the prostate (TUR-P) under spinal anesthesia. All participants will be recruited from a single tertiary care center. Patients will be evaluated preoperatively, and eligible individuals who provide written informed consent will be included in the study.

You may qualify if:

  • Adult patients aged 18-75 years
  • American Society of Anesthesiologists (ASA) physical status I-III
  • Scheduled for elective transurethral resection of the prostate (TUR-P)
  • Planned spinal anesthesia
  • Ability to provide written informed consent

You may not qualify if:

  • Refusal to participate in the study
  • Body mass index (BMI) \>30 kg/m²
  • Use of angiotensin-converting enzyme inhibitors or angiotensin receptor blockers
  • Emergency surgery
  • Baseline systolic arterial blood pressure \<90 mmHg or mean arterial pressure \<70 mmHg
  • Major peripheral vascular disease or severe cardiovascular disease
  • Unstable angina or left ventricular ejection fraction \<40%
  • Chronic respiratory disease
  • Increased intra-abdominal pressure
  • Autonomic nervous system disorders
  • Implanted pacemaker or implantable cardioverter-defibrillator
  • Anticipated difficult airway
  • Cognitive impairment or inability to cooperate

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Health Sciences, Antalya Training and Research Hospital

Antalya, Muratpasa, 07030, Turkey (Türkiye)

RECRUITING

Study Officials

  • Kerem Inanoglu, Medical Doctor

    University of Health Sciences, Antalya Training and Research Hospital

    STUDY DIRECTOR

Central Study Contacts

Semsettin Ekingen, Medical Doctor

CONTACT

Kerem Inanoglu, Medical Doctor

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER GOV
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor of Anesthesiology and Reanimation

Study Record Dates

First Submitted

March 23, 2026

First Posted

March 27, 2026

Study Start

January 1, 2026

Primary Completion

April 15, 2026

Study Completion

May 30, 2026

Last Updated

March 27, 2026

Record last verified: 2026-03

Locations